Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2019

View Archived Issues

Centyrins shown to fight S. aureus toxins

Attune Pharmaceuticals presents promising data for ATN-249 in hereditary angioedema

Study determines radiation dose of tau-selective radiotracer 18F-APN-1607

Pfizer initiates phase II study of PF-05221304 plus PF-06865571 in patients with NAFLD

Patient enrollment ongoing in phase II study of CFI-400945 in advanced/metastatic breast cancer

Study more than doubles known osteoarthritis risk genes

Novel ghrelin inverse agonist as therapeutic candidate against obesity-related metabolic diseases

AS-2762900-00 prevents epidermal hyperplasia in xenograft model of psoriasis

Topline 12-month data update given for phase I/IIa SCiStar study of OPC1

Ipsen presents new modified recombinant BoNT/F7-1 with enhanced potency

Z-11 promotes brain oxidant defense systems in cerebral ischemia reperfusion injury

Lemborexant does not affect driving performance after bedtime in healthy adults and elderly

Talee Bio awarded funds to advance two gene therapies for cystic fibrosis

Results from phase I/II study of rituximab biosimilar ABP-798 in rheumatoid arthritis

First-in-class anti-Wolbachia molecule AWZ-1066S shows promise for filariasis

Origenis and Expansion Therapeutics to jointly discover compounds for RNA-mediated diseases

European Commission approves Rubraca as maintenance treatment for relapsed ovarian cancer

EPOS-Iasis Research and Development patents new conjugates for bone cancer

FDA places clinical hold on IND for MRT-5201 in OTC deficiency

Philogen opens phase II study to explore L19TNF with doxorubicin in metastatic soft tissue sarcoma

Alnylam initiates phase III trial of vutrisiran in hereditary transthyretin amyloidosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...